ÂÜÀòÂÒÂ×

Nicolas Beuzen is an experienced investment professional currently with i&i Biotech Fund since January 2024. Prior experience includes serving as Director of Business Development & Licensing at Molecure, where responsibilities encompassed in- and out-licensing activities, deal structuring, and financial analysis from January 2016 to December 2023. As the founder of MMKB Life Science, Nicolas provided consultancy in early-stage R&D and product strategy in central and eastern Europe from December 2013 to January 2016. Previous roles include small business ownership at Petite France, VP Development and Chief Scientific Officer at Selvita, and project management roles at Ethypharm and EUSA Pharma. Nicolas holds a PhD in Molecular Biology from the University of Glasgow, an MSc in Pharmaceutical Marketing and Management from iaelyon School of Management, and a Bachelor's Degree in Applied Biology from London South Bank University.